Grigorios Siokas Purchases 133,953 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 133,953 shares of the company’s stock in a transaction dated Tuesday, January 6th. The stock was purchased at an average cost of $0.54 per share, for a total transaction of $72,334.62. Following the completion of the transaction, the chief executive officer owned 6,850,724 shares of the company’s stock, valued at $3,699,390.96. This represents a 1.99% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Friday, December 19th, Grigorios Siokas purchased 88,314 shares of Cosmos Health stock. The stock was purchased at an average price of $0.49 per share, with a total value of $43,273.86.
• On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was acquired at an average price of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.68 per share, for a total transaction of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas acquired 51,315 shares of Cosmos Health stock. The shares were acquired at an average price of $0.62 per share, with a total value of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas bought 61,614 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.65 per share, for a total transaction of $40,049.10.

Cosmos Health Stock Down 3.3%

Shares of COSM traded down $0.02 during trading hours on Wednesday, reaching $0.52. The company’s stock had a trading volume of 485,825 shares, compared to its average volume of 327,760. The company has a 50 day moving average of $0.60 and a two-hundred day moving average of $0.73. The company has a quick ratio of 0.84, a current ratio of 0.99 and a debt-to-equity ratio of 0.25. The firm has a market cap of $19.46 million, a price-to-earnings ratio of -0.69 and a beta of 5.37. Cosmos Health Inc. has a 1-year low of $0.28 and a 1-year high of $1.32.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. The company had revenue of $17.11 million for the quarter, compared to analysts’ expectations of $16.40 million. As a group, research analysts predict that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC boosted its position in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 225,507 shares of the company’s stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 at the end of the most recent quarter. 12.61% of the stock is owned by institutional investors.

Analyst Ratings Changes

COSM has been the subject of a number of research reports. Wall Street Zen raised Cosmos Health to a “hold” rating in a research report on Saturday, September 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.